Provided by Tiger Trade Technology Pte. Ltd.

Castle Biosciences, Inc.

35.17
-0.0900-0.26%
Volume:66.05K
Turnover:2.33M
Market Cap:1.07B
PE:-53.75
High:35.92
Open:35.56
Low:34.79
Close:35.26
52wk High:44.28
52wk Low:17.72
Shares:30.55M
Float Shares:28.22M
Volume Ratio:0.23
T/O Rate:0.23%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.6542
EPS(LYR):-0.8334
ROE:-4.20%
ROA:-1.36%
PB:2.29
PE(LYR):-42.19

Loading ...

Oct 01, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 14, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 11, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 25, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 24, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 14, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 14, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 31, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 31, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 31, 2026

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 31, 2026

Major Issues Report

Form 8-K - Current report
Jul 01, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 17, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 01, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 29, 2026

Major Issues Report

Form 8-K - Current report
May 15, 2026

Beneficial Ownership Change

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
May 15, 2026

Beneficial Ownership Change

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
May 07, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 07, 2026

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 06, 2026

Major Issues Report

Form 8-K - Current report